阿尔茨海默氏症的金属结合氨基-β及其对体自组合的影响
1Department of Biosciences and Nutrition, Karolinska Institutet, 141 52 Huddinge, Sweden.
Accounts of chemical research
|September 21, 2023
概括
金属离子,如铜和,与粉样蛋白-β (Aβ) 结合,形成抑制Aβ聚合的复合物. 这种金属结合相互作用为阿尔茨海默病病理学和潜在的治疗策略提供了分子理解.
科学领域:
- 生物物理学的生物物理.
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 金属离子与阿尔茨海默病 (AD) 病理学有关,因为它们在粉样ββ (Aβ) 聚合中的作用.
- 功能障碍的金属稳态与阿尔茨海默病的发展有关,在粉样斑块中观察到金属离子水平升高.
研究的目的:
- 为金属结合的Aβ复合体的分子结构和动态提供详细的见解.
- 用生物物理技术和理论模型阐明金属离子对Aβ聚合过程的影响.
主要方法:
- 高分辨率和低分辨率的生物物理技术,包括NMR光谱学 (放松分散和偏磁性NMR).
- 开发理论运动模型来分析宏观聚合行为并推断微观核化事件.
- 批量聚合率的量化和金属-Aβ复合体中的结构约束的确定.
主要成果:
- 过渡金属离子 (Cu ((II), Zn ((II), Ag ((I)) 与Aβ的N端区域形成紧的复合体,存在于折叠和展开状态之间的动态平衡.
- 金属-Aβ相互作用在低度下抑制了Aβ纤维的形成,在高度下促进了无形聚合物的形成.
- 金属结合主要减少纤维末端延长,这是一个特定的核化步骤,导致整体Aβ聚合动力学减缓.
结论:
- 金属与Aβ单体结合会产生一个看似惰性的复合物,减少聚合易发的池,并减缓宏观聚合.
- 这为金属离子如何调节阿尔茨海默病中的Aβ自我组装和神经毒性提供了分子理解.
- 金属离子可以被认为是对抗Aβ自我组装的最小化剂,为AD提供了潜在的治疗点.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Metal-Ligand Bonds
20.9K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
20.9K
Complexation Equilibria: Factors Influencing Stability of Complexes
398
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
398
Complexation Equilibria: The Chelate Effect
546
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
546
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513


